Pfizer (NYSE:PFE) announced positive outcomes from the Phase 3 VERITAC-2 clinical trial, showing vepdegestrant's promise in treating advanced breast cancer, which could be a significant driver of the ...

Shortly after Starboard Value pitched four nominees for Kenvue's | Activist investor Starboard Value proposed four additions ...

Starboard Value LP underperformed peers in 2024, a year in which Jeff Smith’s activist firm was frustrated with large ...

Activist investor Starboard Value has launched a broadside against Pfizer's leadership under chief executive Albert Bourla, claiming at least $20 billion in value – and possibly as much as $60 ...

Pfizer on Monday named the former head of the U.S. health regulator's drug evaluation unit, Patrizia Cavazzoni, as its chief medical officer, bringing back an industry veteran to lead its regulatory ...

Two former Pfizer executives drawn into a campaign by activist investor Starboard Value to shake up the company have withdrawn their support for the plan. Pfizer's ex-chair and chief executive Ian ...

The American hedge fund Starboard Value has acquired a stake in Pfizer Inc. worth $1 billion. This is reported in the Starboard Value press release. Starboard Value is committed to accelerating the ...

Starboard woos former Pfizer CEO and CFO In October 2024, Starboard said that former Pfizer CEO Ian Read and former CFO Frank D'Amelio shared concerns about Pfizer's direction and had offered to ...

Independent directors Sarah Hofstetter, Erica Mann, and Jeffrey Smith join the Board.

Company and Starboard Value LP Enter into Cooperation Agreement SKILLMAN, N.J.--BUSINESS WIRE--Kenvue Inc. (NYSE: KVUE), the world's largest ...